They sit in every bathroom cabinet and office drawer, quietly shaping how we deal with pain, fever and everyday illness.
New research suggests that the way we mix these familiar pills with antibiotics could be quietly accelerating a global health emergency that doctors have feared for years.
From harmless headache helpers to global health concern
In France they are sold as Doliprane and Advil. Elsewhere the boxes read Tylenol, Nurofen or just “paracetamol” and “ibuprofen”. These drugs are the backbone of self-care: we reach for them for fevers, colds, migraines, period pain, backache and the aftermath of a tough workout.
They are available over the counter in supermarkets, petrol stations and 24‑hour pharmacies. Many countries even allow large packs, making it simple to stock up without seeing a doctor.
That familiarity has a downside. People often assume that if a medicine is cheap and widely available, it is also almost risk‑free. So a tablet for a headache seems fine. Two tablets for a cold seems better. Adding them alongside an antibiotic course feels like common sense.
Frequent, casual use of painkillers during antibiotic treatment may be quietly helping bacteria learn how to survive those very antibiotics.
A study from the University of South Australia, published in Nature in August 2025, is now shaking that assumption. Researchers looked at how a common bacterium, Escherichia coli (E. coli), reacted when exposed to both an antibiotic and a painkiller, including drugs similar to those on kitchen shelves around the world.
What the Australian study actually found
E. coli is notorious in medicine. It lives in our gut, where most strains are harmless, but certain types cause urinary tract infections, sepsis and serious intestinal illness. It is also a workhorse in labs, often used to study resistance to drugs.
In this study, scientists exposed E. coli to ciprofloxacin, a widely used antibiotic, either on its own or in combination with a common painkiller. They then watched how the bacteria adapted over time.
Bacteria are masters of survival. When repeatedly exposed to an antibiotic, some cells manage to mutate and resist the drug. Those survivors multiply, and the next generation becomes harder to kill. This is the basic mechanism of antibiotic resistance.
➡️ “I’m a hairdresser and this is the only product I recommend to my 50+ clients with fine hair”
➡️ Mid-flight, the Norwegian military takes control of a bomb dropped by a US fighter jet
➡️ The United States wants to use a supersonic aircraft turbine to power its data centres
➡️ According To A Harvard Professor, Humans Are Built To Sit, Not To Work Out
➡️ Aquarius horoscope for 7 March 2026: today’s decision could shake up your love, money and health
With the painkiller added, something more worrying happened. Resistance to ciprofloxacin still developed, as expected, but the presence of the painkiller appeared to enhance that process and even triggered cross‑resistance to other antibiotics.
The painkiller did not just sit quietly in the background. It seemed to tilt the evolutionary game in favour of tougher, more drug‑resistant bacteria.
The study suggests that when painkillers and antibiotics share the same bloodstream, bacteria may face a more complex chemical landscape. That environment can nudge them towards mutations and survival strategies that make them less vulnerable to a broad range of drugs.
Antibiotic resistance: a crisis that is already here
Antimicrobial resistance is not a distant sci‑fi risk. The World Health Organization estimates that in 2019, drug‑resistant infections directly caused around 1.27 million deaths worldwide. Doctors are already reporting cases where standard antibiotics fail, forcing them to use last‑resort treatments that are more toxic, more expensive, and sometimes unavailable.
The nightmare scenario is a return to a pre‑antibiotic era. Routine operations, like hip replacements or caesarean sections, would carry far higher risks. Simple urinary infections could become life‑threatening. Cancer chemotherapy, which relies on antibiotics to control infections in vulnerable patients, would become riskier.
Painkillers are just one piece of this puzzle. Overuse of antibiotics in humans, routine use in livestock, and poor sanitation all contribute. Yet the Australian findings suggest that the cocktail of drugs we take, not just antibiotics alone, matters for resistance.
Who is most exposed to the risk?
Not every sore throat treated with a couple of ibuprofen tablets and an antibiotic will create a superbug. The concern lies in repeated, widespread patterns of combined use, particularly in people who take many medicines at once.
- Older adults: more likely to have chronic illnesses, multiple prescriptions and frequent infections.
- Patients in hospitals and care homes: repeatedly exposed to antibiotics and pain relief after surgery or during long stays.
- People with chronic infections: such as recurrent urinary tract infections, who often self-medicate with painkillers while on repeated antibiotic courses.
In these settings, bacteria have more chances to adapt, and drug combinations are common. The study’s co‑author, Professor Henrietta Venter, has argued that doctors and regulators should pay far more attention to how everyday medicines interact with antibiotics, not only life‑saving or specialist drugs.
Should you stop taking ibuprofen and paracetamol?
The short answer is no. These medicines remain important tools for managing pain and fever. They help people function, sleep, and tolerate other treatments, from dental work to chemotherapy.
The message from researchers is not “throw away the painkillers”, but “use them with a bit more thought, especially when antibiotics are involved”.
Painkillers have a place, but reaching for them automatically each time you take an antibiotic may not be as harmless as it feels.
How to use common painkillers more wisely
Personal habits make a real difference. Small changes in millions of households can ease pressure on antibiotics worldwide.
| Situation | Better approach with painkillers and antibiotics |
|---|---|
| Mild fever or discomfort with a viral illness | Use paracetamol or ibuprofen only if the symptoms truly bother you; antibiotics usually are not needed for viruses. |
| Confirmed bacterial infection on antibiotics | Ask a doctor which painkiller is safest alongside your course, and for how long you should take it. |
| Chronic pain with frequent infections | Discuss a full medication review to reduce unnecessary combinations and check for drug interactions. |
Reading the patient leaflet, respecting maximum daily doses and avoiding overlapping products (for example, multiple cold remedies that all contain paracetamol) also lowers the risk of side effects like liver damage or kidney strain.
How these drugs might be changing bacteria
The exact biological mechanisms are still under investigation. Laboratory work suggests several possibilities:
- Painkillers can alter the chemical environment around bacteria, subtly changing acidity or oxidative stress.
- They may interfere with bacterial cell membranes, pushing microbes to adjust their defences.
- Some compounds could influence how bacteria pump out toxins and drugs, making efflux systems more robust.
None of this means that taking a few tablets will instantly create resistant bacteria. The concern grows when such pressures are applied at large scale, in many patients, day after day.
Key terms that often cause confusion
Antibiotic resistance means that bacteria have changed so that antibiotics no longer kill them effectively. The person does not become resistant; the bacteria do.
Antimicrobial resistance (AMR) is a broader term. It covers resistance not only to antibiotics but also to antivirals, antifungals and antiparasitic drugs.
Over‑the‑counter (OTC) medicine is any drug you can buy without a prescription. OTC status does not mean risk‑free. It simply means the medicine is considered safe enough for use without direct medical supervision when directions are followed.
Imagining daily life if resistance worsens
Picture a common scene: a teenager gets a sports injury, is prescribed an antibiotic for an open wound and takes ibuprofen for the pain. In today’s world, both problems usually settle within days. In a future with high resistance, that wound might fail to respond to standard antibiotics. Hospital admission, intravenous drugs and even surgery could follow.
Another scenario: an elderly person in a care home develops a urinary tract infection. She is given antibiotics and paracetamol for fever and discomfort. If the infecting E. coli strain is resistant, she may become severely ill despite treatment, needing transfer to an intensive care unit where drug‑resistant bacteria are already common.
These cases are not hypothetical for many clinicians. Doctors in parts of South Asia, Africa and Europe already report infections that shrug off multiple antibiotics. The new evidence on painkillers suggests that what looks like a harmless extra pill might be subtly tilting the odds in the bacteria’s favour.
Practical steps for patients and healthcare systems
For individuals, three simple habits help reduce the risk:
- Do not demand antibiotics for viral illnesses such as simple colds or flu.
- Use painkillers at the lowest effective dose for the shortest possible time.
- Tell your doctor or pharmacist about all the medicines you are taking, including OTC drugs and supplements.
For healthcare systems, the Australian findings add pressure to strengthen “antibiotic stewardship” programmes. That means tracking antibiotic use, auditing prescription habits, and updating guidelines to factor in interactions with common non‑prescription drugs like ibuprofen and paracetamol.
Pharmacies may also need to rethink how they advise customers. Short questions at the counter — “Are you on antibiotics at the moment?” or “What other medicines are you taking?” — can help flag risky combinations and prompt a quick referral to a doctor when needed.
As research into drug interactions deepens, regulators could require more data on how everyday medicines affect bacterial behaviour. For the moment, the message is simple: those small white tablets in the cupboard still have their place, but they are not as neutral in the fight against superbugs as we once assumed.